[Effects of emetine and ipecacuana on dopamine central mechanisms. A pilot study]
Abstract:
The lack of any rotational behaviour in unilaterally dopamine lesioned animals after ipecacuana or emetine is a strong indication that these substances lack dopamine receptor stimulating properties when administered systematically. Our results thus support those of Lal et al. (1972). Our results do not allow any conclusions concerning the working mechanism of emetine. However, the lack of central dopamine receptor stimulating properties should probably not be explained by an inability to enter through the blood brain barrier but rather a lack of effect on dopamine receptors. This reasoning would also exclude the dopamine receptors in the chemo-trigger zone as responsible for the emetic effect. In terms of the clinical usage of ipecacuana it seems highly improbable that this usage may cause adverse psychotic like side effects due to stimulation of central dopamine receptors.
More Related Videos
11:26Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake
Published on: September 21, 2017
09:54Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Drugs Affecting Neurotransmitter Release or Uptake
Pathophysiology of Vomiting
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
